Discontinuation report BETNESOL RETENTION ENEMA 5MG/100ML
| Report ID | 149892 |
| Drug Identification Number | 02060884 |
| Brand name | BETNESOL RETENTION ENEMA 5MG/100ML |
| Common or Proper name | BETAMETHASONE |
| Company Name | PALADIN PHARMA INC. |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | BETAMETHASONE |
| Strength(s) | 5MG |
| Dosage form(s) | ENEMA |
| Route of administration | RECTAL RECTAL |
| Packaging size | 7X100mL |
| ATC code | A07EA |
| ATC description | INTESTINALANTIINFLAMMATORY AGENTS |
| Reason for discontinuation | Raw material availability |
| Anticipated discontinuation date | 2022-06-15 |
| Actual discontinuation date | |
| Remaining supply date | 2022-06-15 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 100 BLVD ALEXIS-NIHON, SUITE 600 MONTREAL, QUEBEC CANADA H4M 2P2 |
| Company contact information | 1-866-340-1112 paladincs@endo.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2021-11-25 | French | Compare |
| v1 | 2021-11-25 | English | Compare |
Showing 1 to 2 of 2